Pooled safety analysis of EGFR-TKI therapy in patients with EGFR-mutated non-small cell lung cancer.
Masayuki Takeda
No relevant relationships to disclose
Isamu Okamoto
No relevant relationships to disclose
Kazuhiko Nakagawa
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma